Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test

Clinical trial NCT04264468 · UNKNOWN

Trial details

NCT number: NCT04264468
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer

Start date: 2019-05-14
Primary completion: 2020-03-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.